Chiesi Takes Long View To Build Japan Rare Disease Presence

After expanding its local portfolio through acquisitions and partnerships, Chiesi is now aiming to build its presence in Japan's rare disease sector over the long term, helped by development of global products and possible new alliances. 

Chiesi's aiming to expand its presence in Japan and now discussing further development strategy for the market.
Chiesi's aiming to expand its presence in Japan and now discussing further development strategy for the market. • Source: Shutterstock

Chiesi Farmaceutici S.p.A. is actively expanding its rare disease business in Japan through a subsidiary established there in 2022 and as part of the family-owned Italian firm's global push into this space.

A couple of products obtained through acquisitions and licensing deals have already been commercialized in the country and the firm...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia